ABL2
Disease associated variation - ClinVar
Allele IDTypeNameRS#dbSNPPhenotype IDsChromosomeStartStopReferenceAlternate
97452single nucleotide variantNM_007314.3(ABL2):c.2085A>G (p.Leu695=)386352273MedGen:CN2218091179078317179078317TC
97452single nucleotide variantNM_007314.3(ABL2):c.2085A>G (p.Leu695=)386352273MedGen:CN2218091179109182179109182TC
Disease associated variation - GWASdb
ChrPosSNP ID(dbSNP 142)RefAltOri SNP IDP-valueDrug NameDrug AnnoGWAS TraitHPO IDDO IDAATypeTrait or Drug
1179071756rs1325195GArs13251955.00E-06IgE grass sensitizationHPOID:0010701DOID:4481CUTR-3GWASdb_trait
1179077613rs17277288TCrs172772882.70E-04Atrial fibrillationHPOID:0005110DOID:0050650TmissenseGWASdb_trait
1179079190rs3818433TCrs38184333.92E-05Body Mass IndexHPOID:0001507DOID:9970GintronGWASdb_trait
1179084080rs2274230TGrs22742304.11E-04Response to taxane treatment (placlitaxel)HPOID:0100526DOID:1324Acds-synonGWASdb_trait
1179084408rs9724754CArs97247544.11E-04Response to taxane treatment (placlitaxel)HPOID:0100526DOID:1324CintronGWASdb_trait
1179100710rs17277358CTrs172773584.11E-04Response to taxane treatment (placlitaxel)HPOID:0100526DOID:1324CintronGWASdb_trait
1179124290rs9650996GArs96509963.76E-06Left ventricular massHPOID:0005162DOID:10763GintronGWASdb_trait
Disease associated variation - GWAS Central
Study NameSource Marker AccessionChromosomeMarker StartMarker StopAllelesGene SectionP-value-log(p-value)
GWAS of prostate cancerrs21719581179176398179176398intronic0.8744570.058261541384689905
GWAS of prostate cancerrs121222671179195240179195240intronic0.8292450.0813171384143963
GWAS of prostate cancerrs97247541179084408179084408intronic0.7946250.0998377755614865
GWAS of prostate cancerrs22742291179084268179084268intronic0.4282920.3682600376471
GWAS of prostate cancerrs38184331179079190179079190intronic0.3299120.48160188742828103
GWAS of prostate cancerrs14903111179075755179075755UTR30.2616510.5822776010976309
Disease associated variation - OMIM
Ensembl_gene_ID Approved Gene Symbol MIM Number
ENSG00000143322.19 ABL2 164690